Hong Kong–listed Ziyuanyuan Holdings Group Limited (ZYY) has finalised the placement of 86.00 million new shares under its general mandate, generating estimated net proceeds of HK$42.50 million. Completion took place on 16 April 2026 after subscribers requested an extension from the original 1 April deadline.

The newly issued shares represented 20.00% of ZYY’s pre-issue share count and 16.67% of the enlarged share capital. Total outstanding shares have risen from 430.00 million to 516.00 million.

Post-transaction, controlling shareholder Hero Global Limited’s stake was diluted from 51.12% to 42.60%, while Icon Global Holding Limited’s holding moved from 6.33% to 5.27%. The new subscribers collectively hold 16.67%, with the public float (excluding subscribers) reduced to 35.46%.

Management plans to allocate approximately HK$8.50 million (20% of proceeds) to ongoing administrative and operating expenses and about HK$34.00 million (80%) to purchasing trading goods for the Group’s medical equipment and consumables business.